Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "alexion pharmaceuticals"

Alexion Pharmaceuticals (ALXN) Posts Quarterly Results
American Banking News

ALEXION PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION A...

(Edgar Glimpses Via Acquire Media NewsEdge) Note Regarding Forward-Looking Statements This quarterly report on Form 10-Q contains forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform ... TMC Net, 44 minutes ago
[x]  

10 images for alexion pharmaceuticals

American Banking News, 1 day ago
Waterbury Republican American, 1 day ago
Securities Technology Monitor, 22 hours ago
Forbes.com, 2 days ago
FOX 61, 2 weeks ago
KXXV-TV, 1 week ago
ABC News 4 Charleston, 1 week ago
Waterbury Republican American, 2 weeks ago
Securities Technology Monitor, 2 weeks ago
ETF Channel, 2 weeks ago

Watch for Alexion Pharmaceuticals to Potentially Pullback After Gaining 2.35% Yesterday

(Comtex SmarTrend(R)) Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $185.01 to a high of $190.85. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $186.47 on ...
 Individual.com40 minutes ago SmarTrend Watching for Potential Rebound in Shares of Alexion Pharmaceuticals After 2.03% Loss  Individual.com1 week ago
Forbes.com

Alexion Pharmaceuticals Now #122 Largest Company, Surpassing Praxair

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock Market Holiday List By accessing this page, ...
 EMoneyDaily1 hour ago Alexion Pharmaceuticals: Nice Earnings, Too Expensive?  Vision Monday1 day ago
[x]  

Celgene, Alexion Earnings Top Views, Send Stocks Flying

Celgene and Alexion Pharmaceuticals stocks jumped Thursday after both big-cap biotechs beat third-quarter estimates and raised their guidance. Celgene earnings rose 24% vs. a year earlier to 97 cents a share excluding one-time items, beating ...
 Yahoo! Finance23 hours ago Celgene, Alexion Both Beat And Raise, Stocks Rise  Investor's Business Daily1 day ago stock market ... Celgene, Alexion Both Beat And Raise, Stocks Rise Celgene and Alexion Pharmaceuticals stocks jumped Thursday after both big-cap biotechs beat third-quarter estimates and raised their guidance. Celgene earnings rose 24% vs. a year earlier  Investor's Business Daily22 hours ago
[x]  
Securities Technology Monitor

ALEXION PHARMACEUTICALS : Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells

/PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: CytRx Corporation (NASDAQ: CYTR), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Peregrine Pharmaceuticals Inc. (NASDAQ: ...
 4 Traders8 hours ago Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells  Sys-Con India7 hours ago
[x]  

Alexion Pharmaceuticals' (ALXN) CEO Leonard Bell on Q3 2014 Results - Earnings Call Transcript

Operator Good morning, and welcome to the Alexion Pharmaceuticals, Inc. Third Quarter 2014 Results Conference Call. Today's call is being recorded. For opening remarks and introductions, I would like to turn the call over to Mr. Irving Adler, ...
 Seeking Alpha1 day ago Alexion Pharmaceuticals (ALXN) Q3 2014 Results - Earnings Call Webcast  Seeking Alpha1 day ago

Alexion Beats on Earnings & Revenues in Q3, Guides Up

Alexion Pharmaceuticals ( ALXN ) third-quarter 2014 earnings (including stock-based compensation expense) of $1.14 per share beat the Zacks Consensus Estimate by 9 cents. The earnings beat was attributable to higher-than-expected revenues.
 Yahoo! Finance1 day ago

Alexion Pharma quarterly adj profit beats, raises forecast again

Oct 23 (Reuters) - Alexion Pharmaceuticals Inc reported a better-than-expected adjusted profit on strong sales of its blood disorder drug Soliris and raised its full-year profit forecast for the fourth time this year. Sales of Soliris, Alexion's ...
 CNBC1 day ago UPDATE 1-Alexion Pharma quarterly adj profit beats, raises forecast again  Reuters UK1 day ago
[x]  

Alexion Pharmaceuticals beats by $0.11, beats on revenue

s Editor Alexion Pharmaceuticals (NASDAQ:ALXN): Q3 EPS of $1.27 beats by $0.11. Revenue of $555.15M (+38.6% Y/Y) beats by $13.22M. Shares
 Seeking Alpha1 day ago
Forbes.com

Commit To Purchase Alexion Pharmaceuticals At $95, Earn 5.4% Using Options

Investors eyeing a purchase of Alexion Pharmaceuticals Inc. ( NASD: ALXN ) shares, but tentative about paying the going market price of $173.41/share, might benefit from considering selling puts among the alternative strategies at their disposal.
 Forbes.com2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less